Canadian ADHD Guidelines and Resources
ADHD Assessment and Treatment resources for healthcare providers, learn more by joining the Canadian ADHD Resource Alliance
IMPORTANT: The information, content, and materials provided on this website are intended for informational and educational purposes only. They are not designed to replace professional medical advice, diagnosis, or treatment. The information provided should not be used for diagnosing or treating a health problem or disease, or prescribing any medication or other treatment. Any health care related decisions should be made in consultation with your qualified health care provider. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay seeking it because of something you have read on this website. The use of any information provided on this site is solely at your own risk. The website and The PsychoED Clinic assume no liability for any personal interpretation or misuse of the information provided herein.
The latest 4.1 edition of the Canadian ADHD Practice Guidelines (January 2020) is now available to purchase as a searchable database in both English & French: https://adhdlearn.caddra.ca/purchase-guidelines. Alternatively, a PDF of the Guidelines can be downloaded without cost by clicking here.
The Guidelines:
Review diagnosis, assessment and treatment of ADHD across the lifespan
Are evidence-based on recent peer-reviewed published literature
Involve expert consensus when there is a lack of evidence
Offer practical clinical advice
Provide assessment, treatment and follow-up questionnaires in a fillable PDF format with automatic scoring where applicable in the eToolkit (free with the print copy of the Guidelines or can be purchased separately)
Were developed and reviewed by a multidisciplinary team of ADHD specialists, pediatricians, psychiatrists, psychologists, family physicians, pharmacists, nurses, educators and community stakeholders from Canada and the US
Were fully funded by CADDRA without external financial grants.
The CADDRA Canadian ADHD medication chart is now available for download in a bilingual Canada-wide format (latest update November 2022). Healthcare professionals may find the chart useful when discussing medication with individuals with ADHD and their families.
The chart provides information on ADHD medications available in Canada, including names and full colour illustrations of the medications. The chart indicates whether products are recommended as first or second line treatments by CADDRA, and show starting dose, duration of action, delivery, release mode and indicate dose titration per product monograph. Click here for an online overview of formulary-based access to ADHD medications across Canada.
*Please note this downloadable resource is provided for individual use only. Reproduction requests should be sent to info@caddra.ca
ADHD Psychosocial Chart
CADDRA has developed a new psychosocial chart for use by healthcare professionals when working with individuals with ADHD. It outlines the main elements of psychosocial education and includes practical recommendations for patients. The chart was developed by a CADDRA psychosocial committee led by Dr. Geraldine Farrelly, Clincal Associate Professor, Paediatrics & Psychiatry, University of Calgary, Calgary, Alberta and Dr. Karen Ghelani, psychologist, Chrysalis Psychological and Counselling Services, Markham, ON.
*Please note this downloadable resource is provided for individual use only. Reproduction requests should be sent to info@caddra.ca